De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
Aarti Drugs Beheer
Beheer criteriumcontroles 4/4
Momenteel beschikken wij niet over voldoende informatie over de CEO.
Belangrijke informatie
Prakash Patil
Algemeen directeur
₹27.8m
Totale compensatie
Percentage CEO-salaris | 41.5% |
Dienstverband CEO | 39.8yrs |
Eigendom CEO | 9.7% |
Management gemiddelde ambtstermijn | 11.2yrs |
Gemiddelde ambtstermijn bestuur | 8.2yrs |
Recente managementupdates
Recent updates
Analyse CEO-vergoeding
Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
---|---|---|---|
Jun 30 2024 | n/a | n/a | ₹2b |
Mar 31 2024 | ₹28m | ₹12m | ₹2b |
Dec 31 2023 | n/a | n/a | ₹2b |
Sep 30 2023 | n/a | n/a | ₹2b |
Jun 30 2023 | n/a | n/a | ₹2b |
Mar 31 2023 | ₹28m | ₹11m | ₹2b |
Dec 31 2022 | n/a | n/a | ₹2b |
Sep 30 2022 | n/a | n/a | ₹2b |
Jun 30 2022 | n/a | n/a | ₹2b |
Mar 31 2022 | ₹31m | ₹10m | ₹2b |
Dec 31 2021 | n/a | n/a | ₹2b |
Sep 30 2021 | n/a | n/a | ₹2b |
Jun 30 2021 | n/a | n/a | ₹2b |
Mar 31 2021 | ₹35m | ₹8m | ₹3b |
Dec 31 2020 | n/a | n/a | ₹3b |
Sep 30 2020 | n/a | n/a | ₹2b |
Jun 30 2020 | n/a | n/a | ₹2b |
Mar 31 2020 | ₹19m | ₹7m | ₹1b |
Dec 31 2019 | n/a | n/a | ₹1b |
Sep 30 2019 | n/a | n/a | ₹1b |
Jun 30 2019 | n/a | n/a | ₹888m |
Mar 31 2019 | ₹15m | ₹7m | ₹898m |
Dec 31 2018 | n/a | n/a | ₹863m |
Sep 30 2018 | n/a | n/a | ₹887m |
Jun 30 2018 | n/a | n/a | ₹943m |
Mar 31 2018 | ₹14m | ₹7m | ₹823m |
Compensatie versus markt: De totale vergoeding ($USD 332.23K ) Prakash } is ongeveer het gemiddelde voor bedrijven van vergelijkbare omvang in de Indian markt ($USD 272.00K ).
Compensatie versus inkomsten: De vergoeding van Prakash is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.
CEO
Prakash Patil (77 yo)
39.8yrs
Tenure
₹27,848,000
Compensatie
Mr. Prakash Moreshwar Patil has been the Chairman of the Board of Aarti Drugs Limited since April 2014. Mr. Patil has been the Managing Director of Aarti Drugs Limited since June 1, 2007 and serves as its...
Leiderschapsteam
Naam | Positie | Tenure | Compensatie | Eigendom |
---|---|---|---|---|
Chairman | no data | ₹27.85m | 9.67% ₹ 4.6b | |
Joint MD & Executive Director | 21.5yrs | ₹25.54m | 4.75% ₹ 2.3b | |
CFO & COO | 12.3yrs | ₹11.44m | 1.24% ₹ 594.7m | |
Company Secretary & Compliance Officer | 5.5yrs | ₹1.17m | geen gegevens | |
Whole-Time Director | no data | ₹25.54m | 4.46% ₹ 2.1b | |
Whole-Time Director | 24yrs | ₹3.35m | 0.055% ₹ 26.4m | |
MD & Executive Director | 10.1yrs | ₹25.54m | 4.65% ₹ 2.2b | |
Vice President of Technical | no data | geen gegevens | geen gegevens | |
Managing Director of the Pinnacle Life Science Private Limited | less than a year | geen gegevens | 1.03% ₹ 493.7m |
11.2yrs
Gemiddelde duur
61yo
Gemiddelde leeftijd
Ervaren management: Het managementteam van 524348 is doorgewinterd en ervaren (gemiddelde ambtstermijn van 11.2 jaar).
Bestuursleden
Naam | Positie | Tenure | Compensatie | Eigendom |
---|---|---|---|---|
Chairman | 39.8yrs | ₹27.85m | 9.67% ₹ 4.6b | |
Joint MD & Executive Director | 37.8yrs | ₹25.54m | 4.75% ₹ 2.3b | |
Whole-Time Director | 29.1yrs | ₹25.54m | 4.46% ₹ 2.1b | |
Whole-Time Director | 24yrs | ₹3.35m | 0.055% ₹ 26.4m | |
MD & Executive Director | 12.2yrs | ₹25.54m | 4.65% ₹ 2.2b | |
Chairman Emeritus | 12.2yrs | ₹43.00k | 1.87% ₹ 898.2m | |
Independent Director | 2.4yrs | ₹155.00k | geen gegevens | |
Additional Independent Director | less than a year | geen gegevens | geen gegevens | |
Non-Executive Director | 4.2yrs | ₹100.00k | geen gegevens | |
Independent Director | 3yrs | ₹215.00k | geen gegevens | |
Independent Director | 2.4yrs | ₹155.00k | geen gegevens | |
Additional Independent Director | less than a year | geen gegevens | geen gegevens |
8.2yrs
Gemiddelde duur
61yo
Gemiddelde leeftijd
Ervaren bestuur: De raad van bestuur van 524348 wordt beschouwd als ervaren (gemiddelde ambtstermijn 8.2 jaar).